A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
Clinical trial NCT06045221 · COMPLETED
Trial details
- NCT number
- NCT06045221
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-22
- Primary completion
- 2025-08-22
- Enrollment
- 1698
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.